167 related articles for article (PubMed ID: 4977481)
1. Laboratory characteristics of paratyphoid B vaccines tested in controlled field trials.
Hejfec LB; Levina LA
J Bacteriol; 1969 May; 98(2):502-10. PubMed ID: 4977481
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
3. Controlled field trial with dried sorbed paratyphoid B and typhoid vaccines.
Hejfec LB; Levina LA; Kuz'minova ML; Slavina AM; Levites NE; Abidov AZ; Goncarova LF
Bull World Health Organ; 1971; 45(6):787-94. PubMed ID: 5004428
[TBL] [Abstract][Full Text] [Related]
4. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
Hatunceva NV; Mironova MV; Ryapolova RG
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
[No Abstract] [Full Text] [Related]
5. Status of paratyphoid fever vaccine research and development.
Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
[TBL] [Abstract][Full Text] [Related]
6. The protective activity of various antigen complexes of typhoid and paratyphoid B vaccines: controlled field trials and laboratory studies.
Hejfets LB; Levina LA; Bentsianova TG; Salmin LV
Prog Immunobiol Stand; 1970; 4():561-70. PubMed ID: 4991591
[No Abstract] [Full Text] [Related]
7. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
8. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
Arya SC; Agarwal N
Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
[No Abstract] [Full Text] [Related]
9. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
Verma S; Singh K; Bansal A
Pharmacol Res; 2021 Jul; 169():105652. PubMed ID: 33975015
[TBL] [Abstract][Full Text] [Related]
10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
11. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
[No Abstract] [Full Text] [Related]
12. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine.
Hejfec LB; Levina LA; Kuz'minova ML; Salmin LV; Slavina AM; Vasil'eva AV
Bull World Health Organ; 1968; 38(6):907-15. PubMed ID: 4973021
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of oral and subcutaneous immunization against typhoid-paratyphoid fever (author's transl)].
Krasnoproshina LI
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):151-60. PubMed ID: 4216249
[No Abstract] [Full Text] [Related]
14. Vaccines against typhoid fever.
Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic importance of various methods of determining infectious O-antigenemia in patients with typhoid and paratyphoid fevers A and B].
Cherkasov VL; Rubtsov IV; Erovichenkov AA; Kulakov VN; Tregub AV
Ter Arkh; 1988; 60(11):35-8. PubMed ID: 2467391
[TBL] [Abstract][Full Text] [Related]
16. Experimental study on intradermal antitetanus antityphoid immunization.
Dimache G; Stoean C; Durbacă S; Laşcu N; Croitoru M; Dimache A
Roum Arch Microbiol Immunol; 1992; 51(1-2):53-65. PubMed ID: 1457823
[TBL] [Abstract][Full Text] [Related]
17. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
Gekker VD; Sergeeva NS
Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
[No Abstract] [Full Text] [Related]
18. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
19. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
Schwartz E
N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
[No Abstract] [Full Text] [Related]
20. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
Kheĭfets LB; Stanislavskiĭ ES; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
